|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Gastrointestinal cancer
The Oncologic Implications of Tumor Multiplicity in Intrahepatic
Cholangiocarcinoma
: Its Prognostic Value Might Be Underestimated
So Jeong Yoon, Sunghae Park, Hongbeom Kim, Sang Hyun Shin, Jin Seok Heo, Jinsoo Rhu, Gyu-Seong Choi, Jong Man Kim, Jae-Won Joh, In Woong Han
Cancer Res Treat.
2023;55(3):948-955. Published online February 27, 2023 DOI:
https://doi.org/10.4143/crt.2023.290
Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on
Cholangiocarcinoma
Cells
Boonyakorn Boonsri, Kiren Yacqub-Usman, Pakpoom Thintharua, Kyaw Zwar Myint, Thannicha Sae-Lao, Pam Collier, Chinnawut Suriyonplengsaeng, Noppadol Larbcharoensub, Brinda Balasubramanian, Simran Venkatraman, Isioma U. Egbuniwe, Dhanwant Gomez, Abhik Mukherjee, Supeecha Kumkate, Tavan Janvilisri, Abed M Zaitoun, Thiti Kuakpaetoon, Rutaiwan Tohtong, Anna M Grabowska, David O. Bates, Kanokpan Wongprasert
Cancer Res Treat.
2021;53(2):457-470. Published online October 7, 2020 DOI:
https://doi.org/10.4143/crt.2020.585
Crossref 7
Long Non-coding RNA CASC15 Promotes Intrahepatic
Cholangiocarcinoma
Possibly through Inducing PRDX2/PI3K/AKT Axis
Yuan Zhang, Lufei Zhang, Sinan Lu, Yucheng Xiang, Cheng Zeng, Tianyu He, Yuan Ding, Weilin Wang
Cancer Res Treat.
2021;53(1):184-198. Published online October 5, 2020 DOI:
https://doi.org/10.4143/crt.2020.192
Web of Science 13
Crossref 12
Prognostic Predictability of American Joint Committee on Cancer 8th Staging System for Perihilar
Cholangiocarcinoma
: Limited Improvement Compared with the 7th Staging System
Jong Woo Lee, Jae Hoon Lee, Yejong Park, Woohyung Lee, Jaewoo Kwon, Ki Byung Song, Dae Wook Hwang, Song Cheol Kim
Cancer Res Treat.
2020;52(3):886-895. Published online March 12, 2020 DOI:
https://doi.org/10.4143/crt.2020.023
Web of Science 11
Crossref 7
Efficacy and Safety of Pembrolizumab in Patients with Refractory Advanced Biliary Tract Cancer: Tumor Proportion Score as a Potential Biomarker for Response
Junho Kang, Jae Ho Jeong, Hee-Sang Hwang, Sang Soo Lee, Do Hyun Park, Dong Wook Oh, Tae Jun Song, Ki-Hun Kim, Shin Hwang, Dae Wook Hwang, Song Cheol Kim, Jin-hong Park, Seung-Mo Hong, Kyu-pyo Kim, Baek-Yeol Ryoo, Changhoon Yoo
Cancer Res Treat.
2020;52(2):594-603. Published online December 18, 2019 DOI:
https://doi.org/10.4143/crt.2019.493
Web of Science 46
Crossref 45
An Integrated Nomogram Combining Clinical Factors and Microtubule-Associated Protein 1 Light Chain 3B Expression to Predict Postoperative Prognosis in Patients with Intrahepatic
Cholangiocarcinoma
Liang Chen, Hongyuan Fu, Tongyu Lu, Jianye Cai, Wei Liu, Jia Yao, Jinliang Liang, Hui Zhao, Jiebin Zhang, Jun Zheng, Yingcai Zhang, Yang Yang
Cancer Res Treat.
2020;52(2):469-480. Published online October 7, 2019 DOI:
https://doi.org/10.4143/crt.2019.423
Web of Science 6
Crossref 6
Clinical Benefit of Maintenance Therapy for Advanced Biliary Tract Cancer Patients Showing No Progression after First-Line Gemcitabine Plus Cisplatin
Jaewon Hyung, Bumjun Kim, Changhoon Yoo, Kyo-pyo Kim, Jae Ho Jeong, Heung-Moon Chang, Baek-Yeol Ryoo
Cancer Res Treat.
2019;51(3):901-909. Published online October 4, 2018 DOI:
https://doi.org/10.4143/crt.2018.326
Web of Science 15
Crossref 15
Validation of the Eighth American Joint Committee on Cancer Staging System for Distal Bile Duct Carcinoma
Sun-Young Jun, You-Na Sung, Jae Hoon Lee, Kwang-Min Park, Young-Joo Lee, Seung-Mo Hong
Cancer Res Treat.
2019;51(1):98-111. Published online March 2, 2018 DOI:
https://doi.org/10.4143/crt.2017.595
Web of Science 20
Crossref 20
Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-line Treatment for Patients with Recurrent or Metastatic Biliary Tract Cancer
Changhoon Yoo, Boram Han, Hyeong Su Kim, Kyu-pyo Kim, Deokhoon Kim, Jae Ho Jeong, Jae-Lyun Lee, Tae Won Kim, Jung Han Kim, Dae Ro Choi, Hong Il Ha, Jinwon Seo, Heung-Moon Chang, Baek-Yeol Ryoo, Dae Young Zang
Cancer Res Treat.
2018;50(4):1324-1330. Published online January 8, 2018 DOI:
https://doi.org/10.4143/crt.2017.526
Web of Science 19
Crossref 19
Proximal Resection Margins: More Prognostic than Distal Resection Margins in Patients Undergoing Hilar
Cholangiocarcinoma
Resection
Tae Yoo, Sang-Jae Park, Sung-Sik Han, Seong Hoon Kim, Seung Duk Lee, Tae Hyun Kim, Soon-ae Lee, Sang Myung Woo, Woo Jin Lee, Eun Kyung Hong
Cancer Res Treat.
2018;50(4):1106-1113. Published online November 16, 2017 DOI:
https://doi.org/10.4143/crt.2017.320
Web of Science 15
Crossref 9
Declined Preoperative Aspartate Aminotransferase to Neutrophil Ratio Index Predicts Poor Prognosis in Patients with Intrahepatic
Cholangiocarcinoma
after Hepatectomy
Lingyun Liu, Wei Wang, Yi Zhang, Jianting Long, Zhaohui Zhang, Qiao Li, Bin Chen, Shaoqiang Li, Yunpeng Hua, Shunli Shen, Baogang Peng
Cancer Res Treat.
2018;50(2):538-550. Published online June 1, 2017 DOI:
https://doi.org/10.4143/crt.2017.106
Web of Science 15
Crossref 15
Long-Term Outcome of Distal
Cholangiocarcinoma
after Pancreaticoduodenectomy Followed by Adjuvant Chemoradiotherapy: A 15-Year Experience in a Single Institution
Byoung Hyuck Kim, Kyubo Kim, Eui Kyu Chie, Jeanny Kwon, Jin-Young Jang, Sun Whe Kim, Do-Youn Oh, Yung-Jue Bang
Cancer Res Treat.
2017;49(2):473-483. Published online August 23, 2016 DOI:
https://doi.org/10.4143/crt.2016.166
Web of Science 21
Crossref 21
Rare Incidence of
ROS1
Rearrangement in
Cholangiocarcinoma
Sun Min Lim, Jeong Eun Yoo, Kiat Hon Lim, David Wai Meng Tai, Byoung Chul Cho, Young Nyun Park
Cancer Res Treat.
2017;49(1):185-192. Published online April 27, 2016 DOI:
https://doi.org/10.4143/crt.2015.497
Web of Science 14
Crossref 13
Estimation of the Incidence of Hepatocellular Carcinoma and
Cholangiocarcinoma
in Songkhla, Thailand, 1989-2013, Using Multiple Imputation Method
Seesai Yeesoonsang, Surichai Bilheem, Edward McNeil, Sophon Iamsirithaworn, Chuleeporn Jiraphongsa, Hutcha Sriplung
Cancer Res Treat.
2017;49(1):54-60. Published online May 18, 2016 DOI:
https://doi.org/10.4143/crt.2016.045
Web of Science 6
Crossref 5
Dermatomyositis in a Patient with
Cholangiocarcinoma
Detected by an [
18
F]-Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography Scan
Koung Jin Suh, Jin Kyun Park, Seongcheol Cho, Hyunkyung Park, Hae Woon Baek, Kyoungbun Lee, Dong Soo Lee, Kyung-Hun Lee
Cancer Res Treat.
2016;48(2):848-852. Published online March 18, 2015 DOI:
https://doi.org/10.4143/crt.2014.310
Web of Science 5
Crossref 7
Surgery Alone Versus Surgery Followed by Chemotherapy and Radiotherapy in Resected Extrahepatic Bile Duct Cancer: Treatment Outcome Analysis of 336 Patients
Jung Ho Im, Jinsil Seong, Ik Jae Lee, Joon Seong Park, Dong Sup Yoon, Kyung Sik Kim, Woo Jung Lee, Kyung Ran Park
Cancer Res Treat.
2016;48(2):583-595. Published online July 22, 2015 DOI:
https://doi.org/10.4143/crt.2015.091
Web of Science 38
Crossref 34
Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review
Joon Oh Park, Do-Youn Oh, Chiun Hsu, Jen-Shi Chen, Li-Tzong Chen, Mauro Orlando, Jong Seok Kim, Ho Yeong Lim
Cancer Res Treat.
2015;47(3):343-361. Published online May 18, 2015 DOI:
https://doi.org/10.4143/crt.2014.308
Web of Science 68
Crossref 64
Two Cases of Humoral Hypercalcemia of Malignancy in Metastatic
Cholangiocarcinoma
Seungtaek Lim, Jungwoo Han, Kyeong Hye Park, Won Jai Jung, Yong Kang Lee, Ara Choi, Young Jae Kim, Jong-Chan Lee, Hye Jin Choi
Cancer Res Treat.
2013;45(2):145-149. Published online June 30, 2013 DOI:
https://doi.org/10.4143/crt.2013.45.2.145
Crossref 7
A Case of Combined Hepatocellular-
Cholangiocarcinoma
with Favorable Response to Systemic Chemotherapy
Gun Min Kim, Hei-Cheul Jeung, Dokyung Kim, Joo Hoon Kim, Sang Hyun Yoon, Eun Suk Jung, Sang Joon Shin
Cancer Res Treat.
2010;42(4):235-238. Published online December 31, 2010 DOI:
https://doi.org/10.4143/crt.2010.42.4.235
Crossref 14
Severe Hypothyroidism Induced by Thyroid Metastasis of
Cholangiocarcinoma
Woo Kyun Bae, Hyun Jeong Shim, Yoo Duk Choi, Jin Woong Kim, Sang Hee Cho, Ho Cheol Kang, Ik Joo Chung
Cancer Res Treat.
2009;41(1):56-58. Published online March 31, 2009 DOI:
https://doi.org/10.4143/crt.2009.41.1.56
Crossref 9
Immunohistochemical Study for CD44v6 in Hepatocellular Carcinoma and
Cholangiocarcinoma
Ki Jung Yun, Kwon Ha Yoon, Weon Cheol Han
Cancer Res Treat.
2002;34(3):170-174. Published online June 30, 2002 DOI:
https://doi.org/10.4143/crt.2002.34.3.170
Crossref 4
Immunohistochemical Study of beta-catenin Expression between Hepatocellular Carcinoma and
Cholangiocarcinoma
Ki Jung Yun, Weon Cheol Han, Suck Chei Choi, Tae Hyeon Kim
Cancer Res Treat.
2002;34(2):117-121. Published online April 30, 2002 DOI:
https://doi.org/10.4143/crt.2002.34.2.117
Crossref 7
Multiple Primary Cancers in the Stomach and Different Organs
Byung Moo Jeon, Nam Il Kim, Jung Soo Kim, Hae Myung Jeon, Seung Jin Yoo, Jae Sung Kim, Sung Hoon Kim, Eun Jung Lee
J Korean Cancer Assoc.
1996;28(2):394-404.
Combined High Dose Radiotherapy with Sequential Gemcitabine-Cisplatin Based Chemotherapy Increase the Resectability and Survival in Locally Advanced Unresectable Intrahepatic
Cholangiocarcinoma
: A Multi-Institutional Cohort Study
Jung Ho Im, Jeong Il Yu, Tae Hyun Kim, Tae Gyu Kim, Jun Won Kim, Jinsil Seong
Received July 28, 2023 Accepted December 31, 2023 Published online January 2, 2024
DOI:
https://doi.org/10.4143/crt.2023.886
[Accepted]
Global Expanded Access Program for Pemigatinib in Patients with Previously Treated Locally Advanced or Metastatic
Cholangiocarcinoma
and Fibroblast Growth Factor Receptor Gene Alterations
Anouk Lindley, Gerald Prager, Michael Bitzer, Timothy C. Burn, Christine F. Lihou, Elisabeth Croft
Received November 8, 2023 Accepted February 6, 2024 Published online February 7, 2024
DOI:
https://doi.org/10.4143/crt.2023.1197
[Accepted]
1
Journal Impact Factor 4.6